Endpoints at #JPM24 | Primed to unlock biopharma's next dealmaking wave
Monday, June 3, 2024
7:00 AM -  12:00 PM PT 
Marriott Marquis
SAN DIEGO MARINA

Endpoints is back at BIO. The industry is descending on sunny San Diego with a sense of renewed optimism after a rough year. Just a few steps away from the convention center, we’re kicking off BIO with our exclusive networking breakfast lineup Monday morning. Join us for conversations about the ways US/China policy impacts biotech, gene therapy commercialization and lessons learned from last year — and find out who experts think is winning biotech's comeback.

Choose your pass

SPONSORED BY

Agenda-at-a-glance

Endpoints reporters and editors interview leading experts in biotech and beyond. More to come.

  • 7:00 - 8:15am PT
    Networking breakfast
  • 8:15 - 8:20am PT
    Welcome remarks
  • 8:20 - 9:45am PT
    Series of interviews + panels
  • 9:45 - 10:00am PT
    Networking break
  • 10:00 - 11:45am PT
    Series of interviews + panels

Choose your pass:

Get tickets for one or more — your in-person experience includes a networking breakfast before the sessions begin.

Want to bring the team or entertain clients? Get a table and showcase your company logo.

Can’t make it? Join our livestream at no charge.

Executive pass

  • Access to all in-person sessions on Monday AM
  • Networking, coffee + breakfast
$350
get your ticket

vip table

  • Access to all in-person sessions + networking breakfast
  • Tickets for 8 + company logo on table
$2400
RESERVE a TABLE

virtual Pass

  • Can’t make it to the event in-person? Tune in to the livestream
  • Access to all sessions on June 3
Free
watch online

Speakers

From our very own journalists to industry pioneers to thought leaders, all of our speakers bring unique expertise and insight to the stage.

Andrew Dunn
Biopharma Correspondent
Endpoints News
Andrew Dunn
Arsalan Arif
CEO
Endpoints News
Arsalan Arif
Drew Armstrong
Exec Editor
Endpoints News
Drew Armstrong
John Carroll
Founder & Editor
Endpoints News
John Carroll
Lynn Seely
President & CEO
Lyell Immunopharma
Lynn Seely
Andrew Lam
Managing Director, Head of Biotech Private Equity
Ally Bridge Group
Andrew Lam
Kurt von Emster
Managing Partner, Head of Life Sciences
Abingworth
Kurt von Emster
Jami Rubin
Senior Managing Director
Guggenheim Partners
Jami Rubin
Benjamin Oakes
Co-Founder, President, and CEO
Scribe Therapeutics
Benjamin Oakes
Tim Opler
Managing Director
Stifel
Tim Opler
Nick Shipley
Former Chief Advocacy Officer, BIO
Biopharma Consultant, Former BIO and PhRMA Senior Executive
Nick Shipley
Helen Chen
Global Sector Co-Head, Healthcare and Life Sciences | Greater China Managing Partner
L.E.K. Consulting
Helen Chen
Amber Tong
Senior Editor
Endpoints News
Amber Tong
Aviv Regev
Executive VP, Head of Genentech Research & Early Development (gRED)
Genentech
Aviv Regev
Tom Klima
Chief Commercial & Operating Officer
bluebird bio
Tom Klima
Matthew Gline
CEO
Roivant Sciences
Matthew Gline
Bill Newell
CEO
Sutro Biopharma
Bill Newell
Geeta Vemuri
Founder & Managing Partner
Agent Capital
Geeta Vemuri
Philippe Lopes-Fernandes
Executive VP, Chief Business Officer
Ipsen
Philippe Lopes-Fernandes
Sung Hee Choe
Managing Director for FasterCures
Milken Institute
Sung Hee Choe
Svetlana Lucas
Chief Business Officer
Scribe Therapeutics
Svetlana Lucas
Andrew Dunn

Andrew Dunn

Biopharma Correspondent

Endpoints News

Arsalan Arif

Arsalan Arif

CEO

Endpoints News

Drew Armstrong

Drew Armstrong

Exec Editor

Endpoints News

John Carroll

John Carroll

Founder & Editor

Endpoints News

Lynn Seely

Lynn Seely

President & CEO

Lyell Immunopharma

Andrew Lam

Andrew Lam

Managing Director, Head of Biotech Private Equity

Ally Bridge Group

Kurt von Emster

Kurt von Emster

Managing Partner, Head of Life Sciences

Abingworth

Jami Rubin

Jami Rubin

Senior Managing Director

Guggenheim Partners

Benjamin Oakes

Benjamin Oakes

Co-Founder, President, and CEO

Scribe Therapeutics

Tim Opler

Tim Opler

Managing Director

Stifel

Nick Shipley

Nick Shipley

Former Chief Advocacy Officer, BIO

Biopharma Consultant, Former BIO and PhRMA Senior Executive

Helen Chen

Helen Chen

Global Sector Co-Head, Healthcare and Life Sciences | Greater China Managing Partner

L.E.K. Consulting

Amber Tong

Amber Tong

Senior Editor

Endpoints News

Aviv Regev

Aviv Regev

Executive VP, Head of Genentech Research & Early Development (gRED)

Genentech

Tom Klima

Tom Klima

Chief Commercial & Operating Officer

bluebird bio

Matthew Gline

Matthew Gline

CEO

Roivant Sciences

Bill Newell

Bill Newell

CEO

Sutro Biopharma

Geeta Vemuri

Geeta Vemuri

Founder & Managing Partner

Agent Capital

Philippe Lopes-Fernandes

Philippe Lopes-Fernandes

Executive VP, Chief Business Officer

Ipsen

Sung Hee Choe

Sung Hee Choe

Managing Director for FasterCures

Milken Institute

Moderators

From our very own journalists to industry pioneers to thought leaders, all of our speakers bring unique expertise and insight to the stage.